TickerFacts.

A business in context

EOCN research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-25 · 8004 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 6-K · Current report

    Report date 2026-09-09 · 0001493152-26-041872

  2. 6-K · Current report

    Report date 2026-09-08 · 0001493152-26-041656

  3. 6-K · Current report

    Report date 2026-09-03 · 0001493152-26-041357

  4. 6-K · Current report

    Report date 2026-06-30 · 0001493152-26-041239

  5. 6-K · Current report

    Report date 2026-09-02 · 0001493152-26-041231

  6. 6-K/A · Current report

    Report date 2026-07-22 · 0001493152-26-039207

  7. 6-K · Current report

    Report date 2026-08-19 · 0001493152-26-039109

  8. 6-K · Current report

    Report date 2026-08-17 · 0001493152-26-038663

  9. 6-K · Current report

    Report date 2026-08-14 · 0001493152-26-038436

  10. 6-K · Current report

    Report date 2026-07-31 · 0001493152-26-035621

  11. 6-K · Current report

    Report date 2026-07-29 · 0001493152-26-035185

  12. 6-K · Current report

    Report date 2026-07-28 · 0001493152-26-034933

  13. 6-K · Current report

    Report date 2026-07-22 · 0001493152-26-034237

  14. 6-K · Current report

    Report date 2026-07-16 · 0001493152-26-033451

  15. 6-K · Current report

    Report date 2026-07-08 · 0001493152-26-032504

  16. 6-K · Current report

    Report date 2026-06-22 · 0001493152-26-029478

  17. 6-K · Current report

    Report date 2026-06-08 · 0001493152-26-027640

  18. 6-K · Current report

    Report date 2026-06-02 · 0001493152-26-026756

  19. 6-K · Current report

    Report date 2026-05-14 · 0001493152-26-022873

  20. 6-K · Current report

    Report date 2026-05-06 · 0001493152-26-021404

  21. 6-K · Current report

    Report date 2026-04-14 · 0001493152-26-016472

  22. 6-K · Current report

    Report date 2026-04-09 · 0001493152-26-015824

  23. 20-F · Annual report

    Report date 2025-12-31 · 0001493152-26-014182

  24. 6-K · Current report

    Report date 2026-03-05 · 0001493152-26-008989

  25. 6-K · Current report

    Report date 2026-03-04 · 0001493152-26-008858

  26. 6-K · Current report

    Report date 2026-02-09 · 0001493152-26-005776

  27. 6-K · Current report

    Report date 2026-01-30 · 0001493152-26-004508

  28. 6-K · Current report

    Report date 2025-12-08 · 0001493152-25-026539

  29. 6-K · Current report

    Report date 2025-12-04 · 0001493152-25-026112

  30. 6-K · Current report

    Report date 2025-12-01 · 0001493152-25-025498

  31. 6-K · Current report

    Report date 2025-09-30 · 0001493152-25-025070

  32. 6-K · Current report

    Report date 2025-11-18 · 0001493152-25-024004

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-22 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-09-22 · 1612 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001595353Galmed Pharmaceuticals Ltd.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-22 · 1177 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-08 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2020-12-31$0$0
    2019-12-31$0$0
    2018-12-31$2.04M$2.72M
    2017-12-31$1.08M$1.48M

    Bureau of Labor Statistics · retrieved 2026-09-25 · 9 selected series; gaps remain missing

    Explore the CPI history ↗